Global Arteriovenous Fistula Treatment Market is anticipated to grow steadily at a 5.9% CAGR, potentially hitting US$ 1,356.5 Million by 2033

Arteriovenous Fistula Treatment Market
Arteriovenous Fistula Treatment Market

The global arteriovenous fistula (AVF) treatment market is expected to witness significant growth, the market is expected to be worth US$ 765.8 million in 2023, and reaching an estimated US$ 1.356.5 million by 2033, according to a recent market analysis. This growth is projected at a consistent CAGR of 5.9%, driven by the increasing prevalence of arteriovenous fistula diseases and the growing acceptance of AVF therapy, particularly for patients with end-stage renal disease (ESRD).

Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4128

AVF Therapy: The Preferred Choice for Hemodialysis in ESRD Patients

For ESRD patients requiring hemodialysis, arteriovenous fistulas are the preferred method for vascular access. This growing population of ESRD patients worldwide is fueling the demand for reliable and effective vascular access solutions. AVF therapy offers several advantages over other access methods, including:

  • Reduced infection risk
  • Longer patency (usable lifespan)
  • Improved blood flow rates

Key Takeaways from the Global Arteriovenous fistula treatment industry Study Report by FMI:

  • North America held a 37.2% share of the global market in 2022 with the government’s effective efforts to develop new treatments for the arteriovenous fistula issue. The United States is the leading nation in adopting arteriovenous fistula therapy services, contributing to one-third of the global revenue that year.
  • Europe region, with an overall revenue share of 27.4% in the year 2022, followed North America in demand for arteriovenous fistula therapy services. Germany was figured out to be the leading market in the region, with a 6.5% global revenue share in 2022.
  • There is a considerable need for arteriovenous fistula therapy in nations with a greater prevalence of end-stage renal illness, particularly in Asia. So, FMI predicts that China and India could be two remarkably growing markets through 2033 with 9.4% and 7.7% CAGRs respectively.

Step Into A World Of Informed Decisions Via Our Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-4128

Competitive Landscape for the Arteriovenous fistula treatment industry Players:

Becton Dickinson, Medtronic, B. Braun Melsungen, Cook Medical, Teleflex Incorporated, Fresenius Medical Care, NxStage Medical, and Poly Medicure are some top players in this market. Leading players are adopting strategic partnerships with healthcare providers and medical institutes to enter new regions and access a larger client base. Additionally, they have been vigilant in gaining regulatory licenses and adhering to local healthcare norms, allowing them to succeed in local markets.

Arteriovenous fistula therapy is in high demand, which has given new market participants attractive chances to increase their market share locally and internationally. Meanwhile, established arteriovenous fistula treatment devices and product manufacturers and suppliers are increasing investments to enhance product quality and provide cutting-edge treatment approaches.

Key Segments Profiled in the Arteriovenous Fistula Treatment Industry Survey Report:

By Type:

  • Arteriovenous Fistulas
  • Dural
  • Peripheral
  • Pial or Cerebral
  • Other Fistula Types

By Treatment Type:

  • Drugs
  • Transcatheter Embolization
  • Ultrasound-guided Compression
  • Surgery

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Comprehensive Reports: https://www.futuremarketinsights.com/checkout/4128

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *